title: Eosinophil beta 1 integrin activation state correlates with asthma activity in a blind study of inhaled corticosteroid withdrawal.
authors.forename: Mats W
authors.initials: MW
authors.lastname: Johansson
authors.forename: Steven R
authors.initials: SR
authors.lastname: Barthel
authors.forename: Cheri A
authors.initials: CA
authors.lastname: Swenson
authors.forename: Michael D
authors.initials: MD
authors.lastname: Evans
authors.forename: Nizar N
authors.initials: NN
authors.lastname: Jarjour
authors.forename: Deane F
authors.initials: DF
authors.lastname: Mosher
authors.forename: William W
authors.initials: WW
authors.lastname: Busse
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D002465:Cell Movement / Q000187:drug effects / Q000276:immunology; D004311:Double-Blind Method; D004804:Eosinophils / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D019012:Integrin beta1 / Q000097:blood*; D013375:Substance Withdrawal Syndrome / Q000276:immunology* / Q000378:metabolism*
chemical_list: D000305:Adrenal Cortex Hormones; D019012:Integrin beta1